For decades, Artificial Intelligence (AI) was cast as a background tool—an efficient processor of data, a passive observer
assisting scientists in making sense of complexity [1]. Sustainability, by contrast, was championed as a fundamentally
human pursuit, tied to ethical choices and political will. Yet this dichotomy is now dissolving. Emerging applications
suggest that AI is not simply supporting sustainability but coevolving with it, offering dynamic, context-sensitive
strategies for navigating the environmental and biological crises of our time.
Authors:Astik Mishra,
Upasana Mohapatra Published on:
Paracoccus denitrificans is a metabolically adaptable prokaryote equipped with diverse oxidoreductase enzymes that enable
persistence across soil, marine, and industrial environments. This study reviews key reductase enzyme families, including
flavin, iron, quinone, and chromate/chromate-related reductases, emphasizing their biochemical roles and biotechnological
potential. Flavin reductases catalyze coupled electron transfer, reducing both NAD(P)H to its active nicotinamide form and
FAD to FADH₂.
Authors:Payal M. Oak,
Vojtěch Sedláček Published on:
Advances in next-generation sequencing (NGS) technologies have revolutionized our knowledge of the transcriptome, leading to
the discovery of multiple classes of non-coding RNAs (ncRNAs) across all kingdoms of life. While coding RNA mainly serves
as a template for synthesis of protein, the ncRNAs carry out diverse regulatory functions and modulate gene expression at
multiple stages mainly at epigenetic, transcriptional, post-transcriptional, and translational levels.
Authors:Ankith U M,
Deepika V,
Anitha Peter,
Vimanth S Published on:
Cancer continues to pose a significant global health challenge, prompting continuous research and innovation in therapeutic
modalities. Among the evolving methods and approaches, therapies derived from peptides have emerged as an upcoming frontier,
within the bounds of anticancer treatments. Peptides play a crucial role in pathophysiology, diagnosis, and treatment of
hematologic malignancies. These short amino acid chains influence tumour growth, immune response, and cellular signaling
in leukemia, lymphoma, and multiple myeloma.